Ruth He, MD, PhD
@RuthHe12
Followers
1K
Following
2K
Media
52
Statuses
531
@Columbiacancer medical oncologist specialized in gastrointestinal cancer and research on liver cancer and biliary cancer. All opinions are mine.
Joined September 2019
Anwaar, congratulations! Great job!
A dream realized! 🎉 I presented the STELLAR-303 Phase 3 results today at #ESMO2025 — simultaneously published in The Lancet! Trial met its OS primary endpoint in MSS CRC. From CAMILLA to now, 8 years of relentless work. Full circle. A new era begins. Grateful. 🙏✨@OncoAlert
1
1
4
Learn more about @LombardiCancer's @RideBellRinger event on October 24th and 25th. Join or support the Ruesch Riders team today! https://t.co/Kp0joI08ub
0
2
3
⭐ In this roundtable discussion led by @RuthHe12, #GIOncology experts, like @MarkYarchoan, discuss the state of #HCC treatment, including the challenges in establishing effective perioperative strategies following the failure of #adjuvant atezo/bev: https://t.co/Bvd50MgFfq
0
2
2
What role do IO and IO combinations play in the systemic treatment landscape for pts w/ unresectable HCC? What do the latest trial data say about combining IO with locoregional therapies? Get an expert overview of the expanding role of IO for HCC Med Ed video from Prof.
0
2
28
In vivo CRISPR screens identify modifiers of CAR-T cell function in myeloma - targeting cell cycle inhibitor CDKN1B, or p27 might enhance CAR-T effectiveness. https://t.co/QstZTHYkyz
@MangusoLab @MarcelaMaus
@MassGeneralNews
0
4
21
October is #LiverCancerAwareness Month! At ILCA, we’re sharing the facts, the stories, and the fight against liver cancer. 💬 What’s one thing you wish more people knew about liver cancer? Share your thoughts, stories, or experiences and let’s raise awareness together.
1
5
10
This week, we highlighted research by Narayanan Sadagopan, Hongkun Wang, @ChYin89, @benweinbergmd, @mnoel3232, @ReetuMukherjiMD Xue Geng, @marshalj23, Branden S Moriarity, and @RuthHe12 published in @Nature_NPJ- https://t.co/jxf7mBFjkA. Full search: https://t.co/jcVbXq8iec.
0
2
3
.@benweinbergmd, discussed early results from the phase 2 EXPEL PANC trial (NCT05558982), evaluating BXCL701 plus pembrolizumab (Keytruda) in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) after progression on chemotherapy. https://t.co/KNjrBiIpTQ via @onclive
0
3
5
From palliative care a decade ago to first-line curative intent treatment today, #Y90 radiation segmentectomy has been a welcome advancement in #livercancer treatment. 🧩 https://t.co/ayHAgb1hab
@RSNA @SIRspecialists @cirsesociety @APASLnews @JSHLiver @myESMO @BCLC_group
4
21
84
Fresh off the press! @benweinbergmd @ReetuMukherjiMD @mnoel3232 @marshalj23 @RuthHe12 , Thanks for your contribution to this project. Special thanks to Dr.Narayanan Sadagopan, our graduating fellow. https://t.co/LJMc8fpTvy.
0
4
15
Incredible news! #LR5 (Definite #HCC) criteria of #LIRADS, including #CEUS, are now fully aligned with #OPTN
#liver #transplant @UNOSNews @RadiologyACR @chemshift1
https://t.co/pRGEYa20oi
0
5
22
Mike, congratulations!
@PanCAN @Optum @PennMDForum @Penn_CBIO @PennMedicine @JohnsHopkins @HopkinsMedicine I can't even begin to express what an honor and a privilege it is to work with this group, under @PanCAN 's leadership, and following the path of many amazing predecessors 🙏Thank you a million times over for the opportunity
1
0
1
Cool! 😀
Did a robot case yesterday and this is what my anesthesiologist drew 😅
0
0
2
Stephen, congratulations!
Honored and humbled to accept a new role as Division Chief for Hematology & Oncology at Georgetown starting next month. Excited for all that the future holds for @Georgetown @LombardiCancer with the best colleagues one could ask for.
0
0
2
Honored and humbled to accept a new role as Division Chief for Hematology & Oncology at Georgetown starting next month. Excited for all that the future holds for @Georgetown @LombardiCancer with the best colleagues one could ask for.
92
33
525
Working closely with my multidisciplinary team, I am excited to serve patients in and around the Big Apple, and begin new research projects in liver and biliary cancers. Please check out our website, which is currently being built and updated regularly: https://t.co/phRWT6ISrf
0
2
11
Working closely with my multidisciplinary team, I am excited to serve patients in and around the Big Apple, and begin new research projects in liver and biliary cancers. Please check out our website, which is currently being built and updated regularly: https://t.co/phRWT6ISrf
0
2
11
It has been 2 m since I joined Columbia. With support of colleagues in Hem/Onc and center for liver disease and transplant, I feel well settled into my new role. For those interested, here is my link: https://t.co/5eHgtAhqt5, for new patient: hemoncnewpatients@cumc.columbia.edu
9
6
55
It has been 2 m since I joined Columbia. With support of colleagues in Hem/Onc and center for liver disease and transplant, I feel well settled into my new role. For those interested, here is my link: https://t.co/5eHgtAhqt5, for new patient: hemoncnewpatients@cumc.columbia.edu
9
6
55